Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata P. J. M. TuttonD. H. Barkla Original Articles Pages: 209 - 213
Antitumor activity of 1-alkylcarbamoyl derivatives of 5-fluorouracil in a variety of mouse tumors M. IigoA. HoshiK. Kuretani Original Articles Pages: 203 - 208
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma J. L. MissetG. MathéM. Musset Original Articles Pages: 197 - 202
Adjuvant chemotherapy in breast cancer: Critique and perspectives S. K. Carter General Review Pages: 187 - 195
Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (Hematosarcomas or non-Hodgkin's lymphomas) G. Mathé Editorial Pages: 183 - 186
Bleomycin pharmacokinetics in man D. S. AlbertsH. -S. G. ChenS. E. Salmon Original Papers Pages: 177 - 181
Chemotherapy in the management of extramedullary plasmacytoma E. Wiltshaw Original Papers Pages: 167 - 175
High volume intraperitoneal chemotherapy (“Belly bath”) for ovarian cancer R. B. JonesC. E. MyersV. T. DeVita Original Papers Pages: 161 - 166
Chemotherapy as an adjuvant to surgery in lung cancer K. KarrerN. PridunH. Denck Original Papers Pages: 145 - 159
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with Adriamycin and Baker's Antifolate Stephen W. HallTheodore F. TenczynskiGerald P. Bodey Original Papers Pages: 139 - 144
Hepatic estrogen and progesterone receptors in an estrogen-associated hepatic neoplasm J. S. MacdonaldM. E. LippmanP. S. Schein Original Papers Pages: 135 - 138
Assessment of host defence against infection during chemotherapy of Hodgkin's disease I. AddisonJane BabbageR. Souhami Original Papers Pages: 129 - 133
Prognosis and treatment of acute lymphoblastic leukemia C. JacquillatM. WeilJ. Bernard Original Papers Pages: 113 - 122
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology T. A. ListerM. H. CullenD. Crowther Original Papers Pages: 107 - 112
Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3′,4′-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid Pierre AlbertoRenate PeytremannMario Beretta-Piccoli Original Papers Pages: 101 - 105
New natural products of interest under development at the National Cancer Institute John DourosMatthew Suffness Original Papers Pages: 91 - 100
The role of antitumor antibiotics in current oncologic practice Hugh L. Davis Jr.Daniel D. von HoffMarcel Rozencweig Short Review Pages: 83 - 90
The fluoropyrimidines: Biochemical mechanisms and design of clinical trials Michael A. FriedmanWolfgang Sadée Short Review Pages: 77 - 82
Mitomycin C: Experience in the United States, with emphasis on gastric cancer Philip S. ScheinJohn S. MacdonaldPaul V. Wooley Short Review Pages: 73 - 75
Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate Harvey J. CohenNorman Jaffe Original Papers Pages: 61 - 64
Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer Mario De LenaRoberto ZucaliGianni Bonadonna Original Papers Pages: 53 - 59
In vivo toxicity to lymphoid tissue by 2′-Deoxycoformycin John F. SmythRobert C. YoungDavid M. Young Original Papers Pages: 49 - 51
Correlations between experimental chemotherapy in the murine glioma and effectiveness of clinical therapy regimens Victor A. LevinCharles B. Wilson Original Papers Pages: 41 - 48
Sequential combination chemotherapy in advanced breast cancer Cristina BrambillaPinuccia ValagussaGianni Bonadonna Original Papers Pages: 35 - 39
New drugs under clinical evaluation in the United States Stephen K. Carter Short Review Pages: 15 - 24